by demo | Jul 9, 2020 | News, Press Release
GAINESVILLE, FL, USA, July 9, 2020 /EINPresswire.com/ — Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company developing a best-in-class enzyme therapeutic for an underserved kidney disease indication, today announced three additions to its...
